Stephan Ladisch, M.D., professor of pediatrics and professor of biochemistry and molecular biology, was featured in Medical Xpress for recently published research in the American Society of Hematology journal, Blood. The international study found that prolonged, intense initial treatment in children with multi-system Langerhans cell histiocytosis (MS-LCH) can achieve survival rates as high as 84 percent—a full 15 percent improvement over his previous clinical trial. This research was also featured in Science Codex.
Medical Xpress - Study Shows Longer Treatment for Children With Langerhans Cell Hystiocytosis Improves Survival Rates
Latest News
Julie E. Bauman, MD, MPH, and Sharad Goyal, MD, were among 100 physicians and researchers selected as the 2025 recipients of the Fellow of the American Society of Clinical Oncology (FASCO) designation.
Researchers from the George Washington University School of Medicine and Health Sciences (GW SMHS) publish a new study in Nature Communications identifying a critical protein, And-1, that plays a vital role in repairing DNA damage caused by UVB radiation — the harmful rays from the sun that can…
Community leaders, health professionals, and local residents joined members of the George Washington University (GW) School of Medicine and Health Sciences to celebrate the official ribbon-cutting of the new GW Cancer Prevention and Wellness Center, located on the historic St. Elizabeths campus in…